Charles & Colvard Ltd
CTHR
CTHR was delisted on the 24th of April, 2025.
35 hedge funds and large institutions have $9.93M invested in Charles & Colvard Ltd in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 3 closing their positions.
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
13% more funds holding
Funds holding: 31 → 35 (+4)
26% less capital invested
Capital invested by funds: $13.4M → $9.93M (-$3.52M)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
Top Buyers
| 1 |
Cerity Partners
New York
|
+$33.4K |
| 2 |
FCMT
Founders Capital Management (Texas)
Houston,
Texas
|
+$16.9K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$10.7K |
| 4 |
PA
Parallel Advisors
San Francisco,
California
|
+$8.01K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$7.82K |
Top Sellers
CTHR Hedge Fund Activity: Q2 2022 in Review
35 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Charles & Colvard Ltd (CTHR) for Q2 2022, worth a combined $9.93M — down 26% from $13.4M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new CTHR positions and 3 closed out — a net gain of 5 holders — while 5 added to existing stakes and 8 trimmed.
The largest buyer was Cerity Partners, opening a new position worth an estimated $33.4K. The largest seller was Victory Capital Management, cutting an estimated $238K.
- 35 institutional investors held Charles & Colvard Ltd (CTHR) as of Q2 2022, up from 31 in Q1 2022.
- Funds reported $9.93M of Charles & Colvard Ltd stock for Q2 2022, down 26% quarter-over-quarter.
- 8 funds opened new Charles & Colvard Ltd positions in Q2 2022 and 3 closed out, a net change of +5 holders.
- The largest Charles & Colvard Ltd buyer in Q2 2022 was Cerity Partners, an estimated $33.4K added.
- The largest Charles & Colvard Ltd seller in Q2 2022 was Victory Capital Management, an estimated $238K sold.
Based on aggregated 13F filings for Q2 2022.